Characteristics of included studies
SN | Author | Country | Citation (doi) | Study design | Age range of study population | Source of data (primary or secondary)* | Anthropometric measures used | Macronutrient intervention |
1 | Bahwere et al38 | DRC/SSA | 10.1097/01.inf.0000135663.17018.51 | Prospective cohort | <24/>=24 months | Primary | WHZ | Yes; high energy food, enriched milk or F100 |
2 | Ashraf et al46 | Bangladesh/Asia | 10.1097/01.inf.0000135663.17018.51 | Randomised control trial | 2–59 months | Primary | WHZ, WAZ | Enriched milk |
3 | Ngari et al5 | Kenya/SSA | https://doi-org.ezproxy.u-pec.fr/10.1111/ppe.12348 | Observational cohort | 1–59 months | Secondary | MUAC, WHZ, WAZ, HAZ | None |
4 | Agweyu et al39 | Kenya/SSA | https://doi-org.ezproxy.u-pec.fr/10.1016/S2214-109X(17)30448-5 | Retrospective cohort | 2–59 months | Secondary | MUAC, WAZ, WHZ | None |
5 | Awasthi et al40 | India/Asia | https://doi-org.ezproxy.u-pec.fr/10.3389/fped.2021.790109 | Prospective observational cohort | 2–59 months | Primary | WAZ | None |
6 | Bekele et al43 | Ethiopia/SSA | ISSN 0971–9032 www.currentpediatrics.com | Cross-sectional | 2–59 months | Primary | MUAC | None |
7 | Bokadeet et al26 | India/Asia | https://pmc-ncbi-nlm-nih-gov.ezproxy.u-pec.fr/articles/PMC4697219/ | Longitudinal cohort | 1–59 months | Primary | WAZ | None |
8 | Negash et al28 | Ethiopia/SSA | https://doi-org.ezproxy.u-pec.fr/10.1093/ofid/ofz029 | Observational cohort | 0–15 years | Primary | WAZ | None |
9 | Lazzerini et al25 | Malawi/SSA | https://doi-org.ezproxy.u-pec.fr/10.1016/S2214-109X(15)00215-6 | Retrospective Observational cohort | Under 5 years (we focus on 2–59 months) | Secondary | WAZ | None |
10 | Nantanda et al44 | Uganda/SSA | https://doi-org.ezproxy.u-pec.fr/10.1179/146532808X375404 | Cross-sectional | 2–59 months | Primary | WHZ† | None |
11 | Macpherson et al41 | Kenya/SSA | https://doi-org.ezproxy.u-pec.fr/10.1136/bmjgh-2019-001715 | Retrospective Observational Cohort | 5–14 years | Secondary | MUAC, WHZ | None |
12 | Eckerle et al27 | Malawi/SSA | https://doi-org.ezproxy.u-pec.fr/10.1136%2Fbmjpo-2021-001330 | Observational Cohort | 1–59 months | Primary | MUAC | None |
13 | Hooli et al16 | Malawi/SSA | https://doi-org.ezproxy.u-pec.fr/10.1371/journal.pone.0168126 | Retrospective observational cohort | 0–59 months (focus on the 2–59 months) | Secondary | WAZ, MUAC† | None |
14 | Kiguli et al45 | Uganda, Kenya/SSA | https://doi-org.ezproxy.u-pec.fr/10.1016/j.eclinm.2024.102640 | Randomised control trial | 6 months–12 years | Primary | MUAC, WAZ, WHZ, triceps skinfold thickness | RUTF |
15 | McCallum et al42 | Bangladesh/Asia | https://doi-org.ezproxy.u-pec.fr/10.1016/S2213-2600(23)00098-X | Prospective observational cohort | 3–11 months | Primary | WAZ, MUAC† | None |
*Primary data were data collected by direct participant measurements, while secondary data were data extracted from participant/patient files or hospital records as reported by the individual studies.
†Author provided additional information.
DRC, Democratic Republic of Congo; HAZ, height-for-age z-score; MUAC, mid-upper arm circumference; RUTF, ready-to-use therapeutic food; SSA, sub-Saharan Africa; WAZ, weight-for-age z-score; WHZ, weight-for-height z-score.